UPLC-MS/MS Combined with Microdialysis for Determination of Two Active Components of Chuanxiong Rhizoma Extracts in Rat Brain: Application in Pharmacokinetic Study
Journal of Chromatographic Science · 2025
DOI: 10.1093/chromsci/bmae059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chromatographic Science, 2025. Verfasst von Yu Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Microdialysis, Drugs, Chinese Herbal, Rats, Sprague-Dawley. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Xinglin Young Talent program of the Shanghai University of TCM, National Natural Science Foundation of China.
Abstract (Originalsprache)
Chuanxiong Rhizoma (Chuanxiong), a traditional Chinese medicine, has been widely used to treat various nervous and cardiovascular system-related conditions. Its active components, senkyunolide A (SA) and 3-n-butylphthalide (NBP), have been proven effective in treating nervous system diseases. A new method was established based on microdialysis coupled with ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) to estimate the concentrations of these components in brain extracellular fluid. Chromatographic separation was achieved using an Acquity UPLC BEH C8 column (2.1 × 100 mm, 1.7 μm) with acetonitrile and 0.1% formic acid as mobile phase. The calibration curves of SA and NBP were linear in the concentration ranges of 0.25–100.00 and 0.12–48.00 ng/mL, respectively, with a correlation coefficient above 0.9992. All validation parameters, including intra- and inter-day precision, accuracy, matrix effect and stability, were within the acceptance limits of bioanalytical guidelines. The validated method was successfully applied to study the pharmacokinetics of SA and NBP in rat brain microdialysis after oral administration of Chuanxiong extracts. The results showed that both components penetrated the brain and reached maximum concentrations in the microdialysates of 72.31 and 9.93 ng/mL at 1.50 and 1.58 h, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experiment Center for Science and Technology, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
- Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China.
- Spine Institute, Shanghai University of Traditional Chinese Medicine, Shanghai 200092, China.
- Department of Pharmacy, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
ORCID-Profile: Lingyun Pan
Förderung
- Xinglin Young Talent program of the Shanghai University of TCM
- National Natural Science Foundation of China
Zitieren
APA
Wang, Y., Jin, L., Liu, X., Shu, B., Xu, J., & Pan, L. (2025). UPLC-MS/MS Combined with Microdialysis for Determination of Two Active Components of Chuanxiong Rhizoma Extracts in Rat Brain: Application in Pharmacokinetic Study. Journal of Chromatographic Science. https://doi.org/10.1093/chromsci/bmae059
Vancouver
Wang Y, Jin L, Liu X, Shu B, Xu J, Pan L. UPLC-MS/MS Combined with Microdialysis for Determination of Two Active Components of Chuanxiong Rhizoma Extracts in Rat Brain: Application in Pharmacokinetic Study. Journal of Chromatographic Science. 2025. doi:10.1093/chromsci/bmae059
BibTeX
@article{Wang2025,
author = {Wang, Yu and Jin, Liang and Liu, Xinhua and Shu, Bing and Xu, Jia and Pan, Lingyun},
title = {UPLC-MS/MS Combined with Microdialysis for Determination of Two Active Components of Chuanxiong Rhizoma Extracts in Rat Brain: Application in Pharmacokinetic Study},
journal = {Journal of Chromatographic Science},
year = {2025},
doi = {10.1093/chromsci/bmae059}
}
EUVIMED